We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRU.WS
2301
CALL
DELISTED
Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CRU.WS
$1.31M ﹤0.01%
133,328
WAVC.WS
2302
CALL
DELISTED
Waverley Capital Acquisition Corp. 1 Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
WAVC.WS
$1.31M ﹤0.01%
135,095
IPG
2303
DELISTED
Interpublic Group of Companies
IPG
$1.3M ﹤0.01%
+36,718
New +$1.32M
DHBCW
2304
CALL
DELISTED
DHB Capital Corp. Warrant
DHBCW
$1.3M ﹤0.01%
133,328
GRTS
2305
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$1.29M ﹤0.01%
+314,383
New +$1.67M
LH icon
2306
Labcorp
LH
$25.2B
$1.29M ﹤0.01%
5,713
-19,894
-78% -$4.68M
MODV
2307
DELISTED
ModivCare
MODV
$1.29M ﹤0.01%
11,196
-9,625
-46% -$1.11M
FTPAW
2308
CALL
DELISTED
FTAC Parnassus Acquisition Corp. Warrant
FTPAW
$1.28M ﹤0.01%
130,864
PFTAW
2309
CALL
DELISTED
Perception Capital Corp. III Warrant
PFTAW
$1.28M ﹤0.01%
130,298
WAL icon
2310
Western Alliance Bancorporation
WAL
$8.81B
$1.27M ﹤0.01%
15,346
-12,749
-45% -$1.25M
PL.WS
2311
CALL
DELISTED
Planet Labs PBC Warrants
PL.WS
$1.27M ﹤0.01%
250,000
BARK.WS
2312
CALL
DELISTED
BARK Inc Warrants
BARK.WS
$1.26M ﹤0.01%
340,000
LUXE
2313
LuxExperience B.V.
LUXE
$1.13B
$1.26M ﹤0.01%
+103,021
New +$1.56M
POST icon
2314
Post Holdings
POST
$4.42B
$1.26M ﹤0.01%
18,163
-19,012
-51% -$1.33M
PHR icon
2315
Phreesia
PHR
$689M
$1.25M ﹤0.01%
47,529
-68,991
-59% -$2.11M
IVCPW
2316
CALL
DELISTED
Swiftmerge Acquisition Corp. Warrants
IVCPW
$1.25M ﹤0.01%
+127,686
New +$32.3K
FRONW
2317
CALL
DELISTED
Frontier Acquisition Corp. Warrant
FRONW
$1.25M ﹤0.01%
127,645
DISCK
2318
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$1.25M ﹤0.01%
50,134
-173,916
-78% -$4.72M
AX icon
2319
Axos Financial
AX
$5.58B
$1.25M ﹤0.01%
26,926
+19,061
+242% +$1.01M
PGEN icon
2320
Precigen
PGEN
$1.94B
$1.25M ﹤0.01%
591,863
+575,206
+3,453% +$1.4M
VCXB.WS
2321
CALL
DELISTED
10X Capital Venture Acquisition Corp III Warrants
VCXB.WS
$1.24M ﹤0.01%
+124,999
New +$30.3K
MBB icon
2322
iShares MBS ETF
MBB
$39.1B
$1.24M ﹤0.01%
12,184
-25,360
-68% -$2.65M
V icon
2323
PUT
Visa
V
$701B
$1.24M ﹤0.01%
5,600
-11,200
-67% -$2.42M
PFLT icon
2324
PennantPark Floating Rate Capital
PFLT
$698M
$1.24M ﹤0.01%
+91,552
New +$1.2M
THWWW
2325
CALL
DELISTED
Target Hospitality Corp. Warrant expiring 3/15/2024
THWWW
$1.24M ﹤0.01%
206,200

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.